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Abstract
Genetic differences contribute to variations in the immune response mounted by different
individuals to a pathogen. Such differential response can influence the spread of infectious
disease, indicating why such diseases impact some populations more than others. Here, we
study the impact of population-level genetic heterogeneity on the epidemic spread of differ-
ent strains of H1N1 influenza. For a population with known HLA class-I allele frequency and
for a given H1N1 viral strain, we classify individuals into sub-populations according to their
level of susceptibility to infection. Our core hypothesis is that the susceptibility of a given
individual to a disease such as H1N1 influenza is inversely proportional to the number of
high affinity viral epitopes the individual can present. This number can be extracted from the
HLA genetic profile of the individual. We use ethnicity-specific HLA class-I allele frequency
data, together with genome sequences of various H1N1 viral strains, to obtain susceptibility
sub-populations for 61 ethnicities and 81 viral strains isolated in 2009, as well as 85 strains
isolated in other years. We incorporate these data into a multi-compartment SIR model to
analyse the epidemic dynamics for these (ethnicity, viral strain) epidemic pairs. Our results
show that HLA allele profiles which lead to a large spread in individual susceptibility values
can act as a protective barrier against the spread of influenza. We predict that populations
skewed such that a small number of highly susceptible individuals coexist with a large num-
ber of less susceptible ones, should exhibit smaller outbreaks than populations with the
same average susceptibility but distributed more uniformly across individuals. Our model
tracks some well-known qualitative trends of influenza spread worldwide, suggesting that
HLA genetic diversity plays a crucial role in determining the spreading potential of different
influenza viral strains across populations.
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Author summary
Levels of immunity to strains of H1N1 influenza can vary, depending on the individual.
This strongly influences how the disease spreads in a population. Accounting for such var-
iations is a major challenge for the epidemiology of infectious diseases. We study the effect
of population-level genetic heterogeneity on the epidemic spread of different strains of
H1N1 influenza. We model the immune response of specific ethnicities to a number of
H1N1 viral strains, using this information to study disease spread for these (ethnicity,
viral strain) epidemic pairs. Our results show that larger genetic diversity at the level of
immune response, leading to the presence of susceptibility sub-populations with a broad
distribution of susceptibilities, protects against the spread of influenza in a population.
We also show that populations with a small number of highly susceptible individuals, but
with a large number of less susceptible ones, should exhibit smaller outbreaks than popu-
lations with the same average susceptibility but where it is more uniformly distributed.
Our work captures some qualitative trends of influenza spread worldwide, providing a
first attempt at understanding how susceptibility heterogeneities arising from variations
in immune response determine disease spread in populations.
Introduction
A central aim of epidemiological studies is to identify factors that place some populations at
greater risk of contracting an infectious disease than others [1]. Such factors can be associated
with each of the three legs of the “epidemiologic triad” for infectious diseases, the combination
of an external causative agent, a susceptible host, and an environment that links these two
together [2]. Each of these could vary across populations. However, even if the causative agent
was unique and environmental factors assumed to be largely common, variations intrinsic to
the host can lead to large inhomogeneities in epidemic progression across populations [1, 2].
Such variations are ignored in standard formulations of compartment models for infectious
diseases, which project all properties of the host onto a small set of states describing the host
status. These states are typically taken to be susceptible, infected or recovered, with respect to
the progress of the disease [3].
The influenza pandemic of 2009 originated in a new influenza virus, pandemic H1N1 2009
influenza A (pH1N1), to which a large fraction of the population lacked immunity [4]. The
virus responsible is thought to have arisen from a mixture of a North American swine virus
that had jumped between birds, humans and pigs, with a second Eurasian swine virus that cir-
culated for more than 10 years in pigs in Mexico before crossing over into humans [4]. This
pandemic caused extensive outbreaks of disease in the summer months of 2009, across the
USA, Brazil, India and Mexico, leading on to high levels of disease in the winter months. The
pandemic virus had almost complete dominance over other seasonal influenza viruses and was
unusual in its clinical presentation, with the most severe cases occurring in younger age groups
[4].
The severity of the H1N1 2009 pandemic can be assessed in terms of the basic reproduction
number (R0), a fundamental dimensionless epidemiological parameter representing the aver-
age number of secondary infections caused by a typical infectious individual in a fully suscepti-
ble population. An R0 > 1 leads to an expected exponential increase in the number of infected
individuals at early times, an increase which saturates before decreasing as infected individuals
recover, whereas for R0 < 1, the number of infected individuals decreases monotonically. We
compile estimates of R0 values for the pH1N1 epidemic across several countries from the
Impact of genetic heterogeneity on epidemiology of H1N1 influenza
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literature, and list them in Table 1. Substantial variation in R0 values, ranging from about 1.2 at
the lower end to values of 3 and above at the upper end, is evident from this table. This varia-
tion across countries illustrates the need to account for host-specific susceptibilities to disease.
The immune response of the host, modulated by prior infections and vaccinations, is usually
the central factor influencing R0, although location-specific contact rates and health-seeking
behaviour contribute as well. In this work, we study how the spread of influenza in a popula-
tion is affected by variation in naïve host immune response.
Epidemics are typically modelled through deterministic compartmental-type models, rep-
resented by coupled non-linear ordinary differential equations. The SIR model is particularly
well suited for studying the spread of influenza, since H1N1 is a virus which spreads from per-
son-to-person through contact, without requiring a vector for transmission. The lack of a long
incubation period and a relatively rapid recovery makes it possible to ignore the effects of
immigration and emigration, as well as of births and deaths due to natural causes [3]. Models
such as the SIR model and related models typically assume that individuals in the population
are all alike, which allows one to reduce the number of model parameters to be estimated from
data, and leads to mathematical models that can be more feasibly studied from an analytical or
computational perspective. However, increasing efforts have been devoted during recent years
to assessing the impact of individual heterogeneities in disease spread [14]. These heterogene-
ities can be of very different nature, when considering for example populations structured in
specific spatial configurations [15–19], such as households [20] or age-structured populations
[15], or when there exist heterogeneous individual susceptibilities, infectivities or recovery
periods due, for example, to genetic [15, 21] or behavioural [22] reasons. Network or individ-
ual-based models provide a methodology for simulating each individual as a separate entity
(an agent) with a specified susceptibility, an individual-specific ability to infect others as well
as a specified time to recovery, while also being flexible enough to incorporate specific interac-
tion patterns between agents. Such models, however, typically require estimating a large num-
ber of parameters. Individual-based models come with substantial overheads in terms of
computational resources. In addition, their inherent stochasticity makes extensive averaging
necessary [23, 24].
A straightforward generalisation of the simplest version of the SIR model involves sub-
dividing populations into smaller groups or sub-populations. Individuals in each sub-popula-
tion can be considered to be homogeneous, but individuals across different sub-populations
can be modelled as responding differentially to the disease, as in the models of [18–21, 25–29].
Prior work has mainly focused on the theoretical analysis of these models, and relatively few
attempts have been made to incorporate clinical or biological heterogeneities known to be rele-
vant at the individual level, into population-level epidemic models. Incorporating such
Table 1. R0 values for the pH1N1 epidemic in different parts of the world, compiled from literature.
Strain Country Basic reproduction number (R0) Reference
A/H1N1 (2009) New Zealand 1.55 (95% confidence interval: 1.16 to 1.86) [5]
A/H1N1 (2009) USA 1.3–1.7 [6]
A/H1N1 (2009) Iran 1.32 (95% confidence interval: 1.11 to 1.59) [7]
A/H1N1 (2009) India 1.45 [8]
A/H1N1 (2009) Singapore 1.2–1.6 [9]
A/H1N1 (2009) Canada 1.57 (urban) and 3.91 (rural) [10]
A/H1N1 (2009) China 1.68 [11]
A/H1N1 (2009) Japan 2.0 to 2.6 (Early May); 1.21 to 1.35 (May-July) [12]
A/H1N1 (2009) Mexico 1.72 (Mexico City) [13]
https://doi.org/10.1371/journal.pcbi.1006069.t001
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individual-level immunological information into population-level epidemic models account-
ing for susceptibility or infectivity heterogeneities has been recently identified as a major chal-
lenge for mathematical epidemiology [30].
Both innate and adaptive immune responses are initiated when an individual is exposed to
the influenza virus. The innate response induces chemokine and cytokine production. Type I
interferons are among the most important cytokines produced by the innate immune response
and act to stimulate dendritic cells (DCs), enhancing their antigen production. The adaptive
immune system can recognise the presence of an intracellular virus and mount a response
only if a molecule called the human leukocyte antigen (HLA) binds to and ‘presents’ fragments
of viral proteins (epitopes) to the extracellular environment. Professional antigen presenting
cells such as DCs present viral antigens to CD4+ T-cells through HLA class-II and to CD8+ T-
cells through HLA class-I molecules. The CD4+ T-helper cells promote a B-cell response and
antibody secretion. HLA class-I molecules can be found on the surface of all cells, and interact
with T-cell receptors (TCRs) present on CD8+ T-cells [31, 32]. These cells are also called cyto-
toxic T lymphocytes, or CTLs.
The central role of HLA-mediated presentation of antigens in the magnitude and specificity
of CTL response in infectious diseases in general [33], and in influenza A in particular [34, 35],
have been well studied. A recent study shows that the targeting efficiency of HLA, a function of
the binding score of a given HLA allele and the conservation score of a given protein, corre-
lates with the magnitude of the CTL response, and also with the mortality due to influenza A
infection [36]. These studies also show that considering a single HLA allele is insufficient to
determine the strength of the CTL response [34, 37].
Each individual has 6 HLA class-I alleles, the combination of all 6 alleles being referred to
as an HLA genotype. Cross-reactivity between HLA alleles can result in two individuals with
completely different HLA genotypes presenting the same number of high affinity epitopes
[38]. Also, some alleles correlate with stronger (HLA-A02 [34]) or weaker (HLA-A24 [36])
CTL response to the influenza A virus. This raises a number of questions. Does a high risk
allele always correlate with a severe influenza epidemic, or can the presence of diverse HLA
alleles offset this risk? Are there specific patterns of susceptibility resulting from diversity in
HLA, which can confer greater protection to a population? We answer these questions by
using the full HLA genotype of each individual, and with an assumption that a person who
presents a larger number of high affinity viral epitopes will mount a stronger CTL immune
response than one who presents a smaller number [33–37, 39–43]. We use genetic diversity in
HLA alleles to inform epidemiological parameters at the population level and study their influ-
ence on the epidemiological spread of H1N1 influenza.
We assume that all other factors affecting disease spread, such as contact patterns [44],
health-seeking behaviour [45] and migration [46] are uniform among all individuals in a pop-
ulation, and across all populations. Such factors have been studied in the literature [44–46],
largely using theoretical models or data collected for small cohorts. Immunological memory of
an individual is also an important aspect of the immune response, and can be affected by fac-
tors such as the strain with which an individual was first infected [47, 48], prior history of
infections [48] and inherited factors [49]. For lack of data regarding these factors, the model
described in this work does not incorporate age and immunological history explicitly. To offset
this limitation, we focus first on H1N1 strains isolated during the 2009 pandemic, for which
immunological memory and vaccination proved insufficient to curb the spread of disease [4,
50]. We mine this data for characteristics which correlate with epidemic size, and test whether
these correlations hold for strains isolated in years other than 2009.
In a previous paper [51], we developed a method to group together individuals who can be
expected to have a similar CTL response, using the frequency of occurrence of HLA class-I
Impact of genetic heterogeneity on epidemiology of H1N1 influenza
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alleles and the full proteome of the pathogen. We formulated an algorithm to generate all
possible HLA genotypes given the frequency of occurrence of each allele in a particular popu-
lation. Algorithms available through the IEDB resource [52] were used to predict the epitopes
presented by each such HLA genotype. Clustering was then carried out on these HLA geno-
types based on the number of epitopes presented from each viral protein. In this work, we use
the algorithm presented in [51] to generate HLA genotypes and thereby predict high affinity
epitopes presented by each such genotype. We thus identify sub-populations of individuals
with comparable susceptibility to the virus. The relevant parameter in this case is the total
number of such epitopes presented, irrespective of the viral protein from which these epi-
topes originate. We cluster individuals into groups based on this information, and use the
clustering results to calculate the rate at which susceptible individuals become infected. This
rate can be connected to the parameter β which appears in the conventional compartmental
SIR model, which can be used to track the progress of the epidemic through the population.
The prevalence of different HLA class-I alleles in different parts of the world is available
through the Allele Frequency Net Database (AFND) [53]. Each population in the AFND is
given an ethnicity tag. We predict epidemic sizes using our model for 61 such ethnicities, as
well as for 81 strains of influenza A (H1N1) virus isolated in 2009, and 85 strains isolated
before or after 2009, for which the genome (and hence proteome) sequence is known
[54, 55].
Our results show that if we assume that the susceptibility of a given individual is inversely
proportional to the number of high affinity epitopes that this individual presents for a given
viral strain, we can qualitatively reproduce some known trends of influenza spread world-
wide. Moreover, although the basic reproduction number R0 for a given population and a
given viral strain remains the main parameter that controls the epidemic size, other charac-
teristics of the population can also significantly impact epidemic spread. In particular, we
show that a composition of HLA genotypes which results in sub-populations with widely
differing susceptibilities confers protection against the spread of influenza. Moreover, popu-
lations where most of the individuals are less susceptible but where a small sub-set of individ-
uals is highly susceptible, are better in terms of containing the disease than populations that
are otherwise configured, even if they have the same value of R0. We show that the full distri-
bution of susceptibilities across a population is required to predict the final epidemic size,
but that one can extract useful information from low order moments of this distribution.
Although these results are derived from pH1N1 strains, we find that the same trends apply
even for viral strains isolated before or after 2009. We also show that populations with fre-
quent occurrence of an allele associated with high risk for one strain do not always experience
severe epidemics when considering influenza strains in general. We verify these conclusions
by comparisons to synthetic data.
Materials and methods
To model epidemics at the population level, we use a deterministic SIR epidemic model. We
describe a population as being formed out of a number of sub-populations. Each sub-popula-
tion is defined according to their specific susceptibility to the viral strain. To define these sub-
populations in practice, starting from biological data, we employ the probabilistic method
developed in [51]. This method uses well-tested and benchmarked algorithms for epitope pre-
diction [52] to predict the viral epitopes presented by individuals represented by different
HLA class-I genotypes. We link these genotypes to individual susceptibility against the patho-
gen. We can then group individuals with comparable susceptibilities into well-defined sub-
populations.
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We represent different epidemic scenarios in terms of epidemic pairs, formed by consider-
ing both the pathogen (different influenza strains) and the specific population (in this work,
ethnicities) with different sub-population structures. We then use the SIR framework to track
the spread of influenza through the population. The ordinary differential equations used in the
model are coded in Matlab and solved numerically using Matlab’s ode45 solver.
Generating HLA class-I genotypes
The frequency of different HLA class-I alleles for different ethnicities estimated through large-
scale genotyping is available from public databases [53]. Each individual possesses three pairs
of HLA class-I genes. One HLA-A, -B and -C allele is obtained from each parent. Provided we
assume that these 6 alleles occur independent of each other, we can draw 2 genes each from
the full set of possible A, B and C alleles, sampling them according to the empirically measured
prevalence of that allele in the population. Each combination of 6 alleles is referred to as an
HLA genotype. The likelihood of finding an individual with the exact HLA genotype gener-
ated, is given by the product of the likelihood of finding each of the 6 alleles comprising the
genotype. A generated genotype is only accepted if the likelihood of finding an individual with
that genotype is larger than 10−6.
Forming susceptibility sub-populations
An adaptive CD8+ T-cell mediated immune response can only be mounted against a virus if
epitopes from the virus are presented by HLA class-I molecules. The binding between the epi-
tope and the passing CTL takes place through a receptor called the T cell receptor (TCR). Not
all TCRs are capable of recognising all viral epitopes. Thus if an individual presents a large
number of high affinity epitopes, it is reasonable to assume that there is an enhanced probabil-
ity that one or more of these epitopes can be recognised by their TCRs. Such individuals can
be argued to have low susceptibility to the virus. Conversely, the ability of the immune system
to present only a small number of epitopes will reduce the chance that they can be recognised.
Such individuals can be argued to be more susceptible to the viral infection. This link between
HLA class-I genotypes and disease susceptibility is supported, among others, by [33–37, 39–
43].
Predicting epitopes. For a given H1N1 influenza viral strain V and particular ethnicity E
forming an epidemic pair (E, V), we predict the entire set of epitopes presented by each HLA
class-I allele in that ethnicity using different algorithms available through the IEDB analysis
resource [52]. A consensus of three algorithms is used: an artificial neural network [56], a sta-
bilized matrix method [57], and a combinatorial peptide-library based method [58]. These
three algorithms use very different approaches for predicting epitopes for a given HLA allele.
In a study carried out by Sette et. al., all peptides with strong binding affinity, IC50< 50nM,
with their cognate allele were found to be immunogenic [59]. We restrict ourselves to predic-
tions with high likelihood of being immunogenic by ensuring coincident prediction by all
three algorithms, and by only considering epitopes with predicted IC50< 50nM. From these
results, we compute the number of high affinity epitopes presented by each individual, repre-
sented by their HLA genotype, in the population.
Susceptibility sub-populations. The clustering of HLA genotypes into sub-populations is
carried out on the basis of the number of epitopes presented, under the hypothesis that more
susceptible individuals present fewer epitopes. Thus, we cluster individuals so that individuals
within the same group present a similar number of epitopes, whereas individuals from differ-
ent groups present different numbers of epitopes. The susceptibility of each such group is
Impact of genetic heterogeneity on epidemiology of H1N1 influenza
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then,
si /
1
ei
ð1Þ
where si relates to the susceptibility of individuals in group i, and ei denotes the average num-
ber of epitopes presented by the HLA genotypes belonging to sub-population i. A discussion
of the proportionality constant is provided in the section Estimating the proportionality
constant.
Using the number of individuals N in the population and the classification of genotypes in
clusters, we can calculate the fraction of individuals xi in each sub-population i 2 {1, . . ., m}, as
xi ¼
number of individuals in cluster i
total number of individuals in the population
: ð2Þ
All the calculations described above are for a single (ethnicity, viral strain) epidemic pair.
The values of all these parameters must be recalculated for each such epidemic pair being stud-
ied, since, among others, the parameter m depends on (E, V).
Mathematical model
For each epidemic pair (E, V) we use an SIR-based model to study the spread of influenza.
Each population is divided into susceptibility sub-populations; see Fig 1. Our main assump-
tions are:
1. The population is closed and spatially well-mixed.
2. All individuals in the population have equal infectivity and recovery rates.
3. Individuals in each sub-population have the same susceptibility.
4. Individuals in different sub-populations have different susceptibilities.
We use the SIR epidemic model of [21], considering a closed population of N susceptible
individuals and a initially infected individuals. The dynamics of the epidemic are represented
by the coupled equations
dSiðtÞ
dt
¼   biSiðtÞIðtÞ; 8i 2 f1; 2; . . . ;mg; ð3Þ
dIðtÞ
dt
¼ IðtÞ
Xm
i¼1
biSiðtÞ   gIðtÞ; ð4Þ
dRðtÞ
dt
¼ gIðtÞ: ð5Þ
Here Si(t), I(t) and R(t) are the numbers of susceptible (at sub-population i), infected and
recovered individuals at time t and initial conditions are given by
Sið0Þ ¼ Ni; 8i 2 f1; 2; . . . ;mg; ð6Þ
Ið0Þ ¼ a Ni; 8i 2 f1; 2; . . . ;mg ð7Þ
Rð0Þ ¼ 0; ð8Þ
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N ¼ N1 þ N2 þ . . .þ Nm; ð9Þ
N þ a ¼
Xm
i¼1
SiðtÞ þ IðtÞ þ RðtÞ: ð10Þ
We use a = 1 in our numerical calculations to represent a single infective individual who
introduces the disease into a fully susceptible population.
Fig 1. Model sketch. The SIR model with susceptibility sub-populations used in this work. (a) Initially, individuals belong to one of the
susceptibility sub-populations. Infection is seeded by a initially infected people. (b) At the end of the epidemic, all individuals are either
recovered or have never been infected.
https://doi.org/10.1371/journal.pcbi.1006069.g001
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The parameter βi governing the infection of susceptible individuals belonging to the ith sub-
population is assumed to be a composite of three factors,
bi ¼ acsi: ð11Þ
We take αsi 2 [0, 1] to represent the probability of a successful contact between a susceptible
individual from the ith sub-population, and an infective individual, leading to infection. The
quantity α accounts for factors such as the infectiousness of the pathogen, or the infectivity of
the infective individual, while si is related to the susceptibility of individuals in sub-population
i. The parameter c represents the average number of contacts per individual per unit time. We
note here that, since the dimensions of c are person−1time−1, βi has dimensions person−1time−1.
An alternative notation in the literature takes the infection rate to have units time−1, with S and
I representing proportion of susceptible or infected individuals, rather than numbers. This
would be equivalent to working with the alternative parameter b^i ¼ biN.
Since individuals in all the ethnicities are considered to be homogeneously mixed and
all our numerical computations are carried out with the same number of individuals
(N + a = 104), we assume the parameter c to be the same for all the epidemic pairs under con-
sideration. Further, since our interest is in analysing the impact of susceptibility heterogene-
ities in the spread dynamics, we take α to be the same regardless of the epidemic pair (E, V)
under consideration. Thus, when comparing the spread dynamics between two epidemic
pairs, heterogeneity in susceptibilities emerges as the main factor in our models determining
the difference in these dynamics.
Finally, we note that the parameter β, given by
b ¼
1
N
Xm
i¼1
Nibi; ð12Þ
can be seen as the counterpart of (β1, . . ., βm) when the population is considered homoge-
neous. It corresponds to the parameter widely used and estimated, usually by estimating the
basic reproduction number R0, in the literature from epidemiological data for different patho-
gens and populations.
Estimating the proportionality constant
For a given (E, V) pair, and using Eq (1), the susceptibility of each sub-population is inversely
proportional to the average number of epitopes presented by individuals in that group. Thus
we can write si ¼ z 1ei where z is a proportionality constant which captures other components
of the immune system that affect susceptibility, including all aspects of the innate and humoral
immune response. We assume these aspects to be the same across all individuals and pairs,
since only heterogeneities related to HLA profiles are considered in this work. Then, βi is given
by
bi ¼ acz
1
ei
¼ y
1
ei
; ð13Þ
where y = αcz accounts for contributions to βi that are assumed to be the same across different
individuals and pairs. The value of β in Eq (12) can be calculated as a weighted average of the
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βi values, as
b ¼
1
N
Xm
i¼1
Nibi ¼
1
N
Xm
i¼1
Niy
1
ei
¼ y
Xm
i¼1
Ni
N
1
ei
¼ y
Xm
i¼1
xi
1
ei
: ð14Þ
The quantity β is henceforth referred to as average susceptibility. We note that our algorithm
reports ei = 0.07 as the minimum value of the average number of epitopes presented by a sub-
population in any epidemic pair, so that β is always finite.
One way to obtain y is to scale to an experimentally determined value for β, given a specific
ethnicity and viral strain (E0, V0). Values for β have historically been estimated using tech-
niques such as serotyping the same set of people at different time points to estimate the change
in the fraction of individuals susceptible to a given pathogen. Other methods are reviewed in
[60]. Once we have a value of β for one epidemic pair (E0, V0), we can calculate values xi and ei
for this epidemic pair using the HLA genotype generation, epitope prediction and clustering
methods outlined above. These can be inserted into Eq (14), allowing us to compute the value
y, which we have assumed to be the same across all epidemic pairs. Values of xi and ei for each
pair (E, V) can be used, together with this value of y, to get a β for any pair (E, V).
In this work, we use the value of R0 estimated in [13] for the Mexico City population for the
2009 H1N1 pandemic originating in Mexico La-Gloria. This was chosen as a reference because
HLA class-I allele frequency for this ethnicity, as well as the protein sequence of this viral strain
were available. In [13], an exponential curve was fit to the data of number of infections over
time during the initial phase of the epidemic. The distribution thus estimated was used to com-
pute R0. The R0 estimated in this manner was 1.72. We use this R0 to compute β for this epi-
demic pair, and use the epitopes and sub-populations for the pair (E0, V0) = (Mexico City
Mestizo pop 2, A/Mexico/LaGloria-8/2009) to estimate y. We note that we are using a particu-
lar β estimated in the literature for a specific pair (E0, V0) for computing y, and then consider-
ing y to be the same across different pairs. By doing this, we are scaling the rate of the event
Si + I! I + I in all the simulations for any pair (E, V) to the value of β obtained from data for
the given pair (E0, V0).
Summary statistics for comparing epidemics
We focus on the following global epidemiological characteristics:
FI1 ¼
Rð1Þ
N þ a
¼ Total fraction of individuals suffering from the infection
during the outbreak;
R0 ¼ Basic reproduction number ¼ Number of secondary infections
caused by a typical infected individual in a fully susceptible population;
until they recover:
In our model, the ability of an individual to transmit the disease does not depend on the
sub-population that the infected individual belongs to, since infectivity is considered to be the
same across sub-populations. The SIR model of Eqs (3)–(10) was analysed in [21], where it
was proved that R(1) is the only positive solution of
N þ a   Rð1Þ  
Xm
i¼1
Nie
 
biRð1Þ
g ¼ 0; ð15Þ
and FI1 can be derived from R(1) by applying FI1 ¼
Rð1Þ
Nþa . The basic reproduction number
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R0 is the number of secondary infections that a typical infected person causes when introduced
into a large population of susceptible individuals. In the classical SIR model for homogeneous
populations, R0 is given by
R0 ¼
bN
g
: ð16Þ
In order to calculate R0 for our system of equations (Eqs (3)–(10)), we consider the case
when a small number of infected individuals is introduced into a large population of N suscep-
tible individuals. We assume the number of susceptible individuals (Si(0) = Ni for all i) to be
large, such that a Ni. This approaches the limit in which there is an unlimited source of sus-
ceptible individuals at the beginning of the epidemic. Then the dynamics of the initially
infected population in terms of a(t), the number of initially infected individuals at time t
declines as
daðtÞ
dt
¼   gað0Þ; ð17Þ
and thus a(t) = a(0)e−γt. Let I(1)(t) be the number of secondary infections caused up to time t,
with I(1)(0) = 0, by the a initially infected individuals. Then
dIð1ÞðtÞ
dt
¼
Xm
i¼1
biSiaðtÞ ¼ að0Þe
  gt
Xm
i¼1
biNi; ð18Þ
so that Ið1ÞðtÞ ¼ að0Þ
Pm
i¼1 biNi
e  gs
  g
h it
0
.
The basic reproduction number is given by
R0 ¼ limt!1 I
ð1ÞðtÞ ¼ að0Þ
Xm
i¼1
biNi
e  gt
  g
 1
0
¼
Pm
i¼1 biNi
g
að0Þ; ð19Þ
so that by setting a(0) = 1 we get
R0 ¼
Pm
i¼1 biNi
g
: ð20Þ
For m = 1, this expression leads to the well-known basic reproduction number for the
homogeneous case (Eq (16)).
Parameters characterising epidemic pairs. Our model predicts values of FI1 and R0 for
each pair (E, V). Any given epidemic pair (E, V) corresponding to an ethnicity E and a viral
strain V has a susceptibility profile described by the number m of sub-populations, and by vec-
tors (β1, . . ., βm) and (N1, . . ., Nm). The susceptibility profile of any epidemic pair (E, V) is
described by a Susceptibility Profile Vector (SPV)
SPVðE;VÞ ¼ ðb1; . . . ; b1|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
N1
; b2; . . . ; b2|ﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄ}
N2
; . . . ; bm; . . . ; bmÞ|ﬄﬄﬄﬄﬄﬄﬄ{zﬄﬄﬄﬄﬄﬄﬄ}
Nm
:
The quantities FI1 and R0 can be expected to directly depend on the SPV(E, V), where we
omit (E, V) from now on for ease of notation. For example, it is clear that for a given epidemic
pair, R0 directly depends on the total number of individuals, N, the recovery rate, γ, and the
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average susceptibility
b ¼
1
N
Xm
i¼1
Nibi ¼ E½SPV:
On the other hand, the quantity of central interest to epidemic modeling, the final epidemic
size FI1 for a given epidemic pair, could depend on the full distribution of the SPV. For con-
creteness, we examine the dependence of FI1 on the lower order moments of the distribution,
such as the standard deviation, the skewness and the coefficient of variation, defined respec-
tively as
sðSPVÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Var ðSPVÞ
p
¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
N
XN
i¼1
ðSPVi   bÞ
2
s
;
SkðSPVÞ ¼ SkewnessðSPVÞ ¼
1
N
XN
i¼1
ðSPVi   bÞ
3
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
N
XN
i¼1
ðSPVi   bÞ
2
s !3 ;
CVðSPVÞ ¼
sðSPVÞ
b
:
We note that a long left tail of the distribution represented by SPV would result in Sk(SPV)<
0, indicating the presence of a small number of individuals with susceptibility significantly
lower than the mean. On the other hand, when the population has a small representation of
individuals with susceptibility significantly higher than the mean, we have Sk(SPV)> 0.
Workflow
The workflow used in this paper is summarised in Fig 2.
Results
To compute FI1, we solve Eqs (3)–(10) with N + a = 104 individuals, a = 1. Each simulation is
allowed to run for (0, T), where time T is large enough to ensure that the epidemic has died
out. In particular, T is chosen to be large enough for each considered epidemic pair so that R
(T) R(1) obtained from the simulation satisfies Eq (15) with some error  < 10−2. The
recovery rate used was γ = 1/3 day−1 [13].
The input to Eqs ((3)–(10)) was determined for 61 ethnicities and 81 viral strains isolated in
2009, leading to the study of 4, 941 epidemic pairs. Of these, 1, 392 cases had R0 > 1, and 718
cases had FI1> 0.5. The distributions of SPV characteristics across these 4, 941 epidemic
pairs is provided in Fig 3. The number m of susceptibility sub-populations varied from 1 (578
cases) to 23 (1 case, A/Giessen/6/2009 with Kenya Nandi ethnicity). The most common value
for m was 5, seen in 647 cases spanning 80 strains and 32 ethnicities. Details regarding ranges
of calculated parameters for strains isolated before or after 2009 can be found in the supporting
information; see S1 Fig. All estimated parameters are provided for all epidemic pairs in a sup-
plementary file; see S1 File.
Results presented in upcoming sections are for H1N1 strains isolated in 2009, unless stated
otherwise.
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Dependence of epidemic size and R0 on average susceptibility
We first examine the relationship between the average susceptibility (β), the basic reproduc-
tion number (R0) and the epidemic size (FI1); see Fig 4. We note that Eq (16) predicts a
linear relationship between R0 and β. As can be seen in Fig 4(a), most (E, V) pairs have β<
2 × 10−4person−1day−1, while pairs with higher values of β correspond to those with large epi-
demic sizes (FI1> 0.6). These pairs have R0 > 7, implying β> 2.33 × 10−4person−1day−1 from
Eq (20).
In Fig 4(b) we focus on epidemic pairs with R0 < 7. In this plot, there are a large number of
points with epidemic size FI1 0. Upon closer examination, these points turn out to have
R0 < 1, as expected. We note that R0 = 1 implies β = 0.33 × 10−4person−1day−1, which corre-
sponds to the point in Fig 4(b) where the epidemic size starts to rise above 0. In all further
plots, we focus on the (E, V) pairs where 1< R0 < 7 and m> 1, leading to the analysis of 956
epidemic pairs.
No single parameter predicts epidemic size
In Fig 4(b), where the relationship between β and FI1 is shown, it can be seen that a high value
of average susceptibility leads to a larger epidemic. The red line corresponds to the epidemic
size when the susceptibility compartment is homogeneous (i.e., m = 1). We see that this line
forms an upper bound on the FI1 values for epidemic pairs with m> 1. It has been proved
that the final epidemic size is always lower in an epidemic pair with heterogeneous susceptibil-
ity, than an epidemic pair with the same average susceptibility but with homogeneous suscepti-
bility [21, 28, 44, 61]. The predictions in our simulations agree with this result. However, we
observe a spread of FI1 values when considering epidemic pairs containing heterogeneous
susceptibilities and having the same average susceptibility β; see Eq (12). This shows that het-
erogeneity plays a role in determining the extent of an epidemic even when the average suscep-
tibility remains constant.
Fig 2. Workflow. Summary of the steps carried out in this work. Inputs from external sources are shown in dotted parallelograms.
https://doi.org/10.1371/journal.pcbi.1006069.g002
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To study what aspects of this heterogeneity have the greatest impact on epidemic size, we
examine the dependence of FI1 on the characteristics of the susceptibility profile vector dis-
cussed above (m, β, σ(SPV), CV(SPV) and Sk(SPV)); see Fig 5. The main trends that can be
identified are the following:
Fig 3. Variations in SPV characteristics, 2009 strains. Histograms for the values of the different susceptibility profile vector characteristics for
the 4, 941 epidemic pairs involving H1N1 strains isolated in 2009: (a) σ(SPV); (b) Sk(SPV); (c) CV(SPV); (d) m; and (e) β.
https://doi.org/10.1371/journal.pcbi.1006069.g003
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• Epidemic pairs leading to positive skewness of the SPV seem to yield smaller epidemic sizes
on average; see Fig 5(a).
• Pairs corresponding to SPV with larger coefficient of variation also yield smaller epidemic
sizes; see Fig 5(c).
• Epidemic pairs containing more sub-populations (larger m) correspond to small epidemic
sizes; see Fig 5(d).
In our data, a positive value for Sk(SPV) corresponds to epidemic pairs with R0 < 2. Fig 4
shows that even with such small values for R0, FI1 can take on a wide range of values, going up
to 0.8. Yet, epidemic pairs in our data set with positive Sk(SPV) always have FI1< 0.2; see Fig
5(a). This suggests that having a positive skewness, corresponding to a distribution where
most of the people have low susceptibility, but a small number of people have susceptibility sig-
nificantly larger than the mean, lends some protective effect to the population.
Although σ(SPV) does not directly affect R0, it influences it indirectly due to the positive
correlation between β and σ(SPV). To remove this correlation, one can analyse CV(SPV)
instead; see Fig 5(c). This figure indicates that epidemic pairs with larger values of CV(SPV)
lead to smaller epidemic sizes.
We provide correlation coefficients r(θ, τ) 2 (−1, 1) between our summary statistics
τ 2 {FI1, R0} and SPV characteristics θ 2 {m, β, CV(SPV), σ(SPV), Sk(SPV)} in Table 2. The
parameter β provides the best predictor for both R0 and FI1. On the other hand, the heteroge-
neity described by CV(SPV), and the skewness of the susceptibility distribution described
through Sk(SPV), also emerge as good predictors of FI1.
To further examine the connections between the SPV characteristics θ 2 {m, β, CV(SPV), σ
(SPV), Sk(SPV)} and τ 2 {FI1, R0} and concentrating specifically on the role of σ(SPV) and m,
we describe two case studies below.
Case study 1—σ(SPV). Fig 5(b) shows that most of the epidemic pairs in our data
set have σ(SPV)< 10−4person−1day−1. Although the correlation between σ(SPV) and FI1 is
Fig 4. R0 cannot predict epidemic size exactly. The dependence of FI1 on R0 and β is shown for: (a) all epidemic pairs involving strains
isolated in 2009; (b) epidemic pairs involving strains isolated in 2009, and with R0 < 7. Only epidemic pairs with m> 1 are plotted. The red line
shows the epidemic size in the case of homogeneous susceptibilities. We see that when R0 > 1, FI1 takes on a wide range of values for any given
R0.
https://doi.org/10.1371/journal.pcbi.1006069.g004
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not statistically significant (see Table 2), we notice that a high value of σ(SPV) (> 1.5 ×
10−4person−1day−1) corresponds to moderate values for FI1. We examine two (E, V) pairs
with high σ(SPV); see pairs 1 and 2 in Table 3 and their corresponding epidemic dynamics
in Fig 6. These two pairs have similar values for σ(SPV), and yet have significantly different
epidemic sizes (0.48 for pair 1, and 0.74 for pair 2). We also see from Fig 6(b) and 6(d), that
the infection runs its course faster in pair 2 than in pair 1. Both these phenomena can be
explained by the fact that pair 2 has a significantly higher β (2.33 × 10−4person−1day−1, com-
pared to 1.42 × 10−4person−1day−1 for pair 1). We can also see from Fig 6 that the sub-popu-
lation with highest βi is the one most affected by the infection, while the sub-populations
Fig 5. FI1 as a function of SPV characteristics. The dependence of FI1 on several characteristics of the susceptibility profile vector of each (E,
V) pair involving an H1N1 strain isolated in 2009: (a) skewness of the SPV; (b) standard deviation of the SPV; (c) coefficient of variation of the
SPV; (d) number of susceptibility sub-populations, m.
https://doi.org/10.1371/journal.pcbi.1006069.g005
Table 2. Correlation coefficients r(θ, τ) between summary statistics of the epidemic and SPV characteristics.
SPV Characteristic, θ FI1 p-value R0 p-value
m −0.51 < 10−3 −0.24 < 10−3
β 0.74 < 10−3 1.00 < 10−3
CV(SPV) −0.61 < 10−3 −0.20 < 10−3
σ(SPV) 0.0004 0.99 0.53 < 10−3
Sk(SPV) −0.39 < 10−3 −0.14 < 10−3
https://doi.org/10.1371/journal.pcbi.1006069.t002
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with low βi remain largely uninfected, in both pairs 1 and 2. We will see in further sections
that β and σ(SPV) together, correlate well with epidemic size.
Case study 2—m. In Fig 5(d) there appears to be some negative correlation between m
and FI1, with larger values of m corresponding to smaller epidemic sizes; see Table 2. How-
ever, we note that this is more an artefact of the data than a predictive trend, and it is possible
to have epidemic pairs with a large value of m but very different final epidemic sizes and epi-
demic time-course dynamics. This can be seen for example in Fig 7 for epidemic pairs 3 and 4
from Table 4. Once again, the pair with higher average susceptibility has both a larger epidemic
size, and also a faster time course for the spread of the disease.
Table 3. Case study 1—Studying the predictive power of σ(SPV).
Pair Ethnicity (E) Strain (V) m β (×10−4) σ(SPV) (×10−4) CV(SPV) Sk(SPV) FI1 R0
1 China North Han A/Fukuoka-C/3/2009 5 1.42 1.59 1.12 0.36 0.48 4.27
2 China Yunnan Province Hani pop 2 A/Auckland/ 1/2009 6 2.33 1.55 0.67 −0.75 0.74 6.99
β and σ(SPV) have units person−1day−1. Histograms of each susceptibility profile SPV(E, V), together with the dynamics of each epidemic, are shown in Fig 6.
https://doi.org/10.1371/journal.pcbi.1006069.t003
Fig 6. Case study 1—σ(SPV). Simulation results for epidemic pairs 1 (a)-(b) and 2 (c)-(d) in Table 3. Distribution of βi values in the population
(left): the x-axis represents values of ln(βi), and the y-axis shows values of Ni. The red vertical line corresponds to the average susceptibility β.
Time course of the epidemic (right) in terms of variables Si(t) (solid) for each sub-population, and I(t) (dashed).
https://doi.org/10.1371/journal.pcbi.1006069.g006
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Dependence of R0 on SPV characteristics
We address the question of whether R0 can be estimated from the SPV characteristics θ 2 {m,
CV(SPV), σ(SPV), Sk(SPV)}; see Fig 8. The linear relationship between β and R0 follows from
Eq (16). In Fig 8(d), we once again observe that (E, V) pairs with m> 10 have low R0. As
observed in case study 2, this is more an artefact of biases in the real data than a general trend.
In Fig 8(b), we plot σ(SPV) against R0. Although σ(SPV) does not directly affect R0, we see this
shape due to the relationship in the data between β and σ(SPV).
Fig 7. Case study 2—m. Simulation results for epidemic pairs 3 (a)-(b) and 4 (c)-(d) in Table 4. Distribution of βi values in the population (left):
the x-axis represents values of ln(βi), and the y-axis shows values of Ni. The red vertical line corresponds to the average susceptibility β. Time
course of the epidemic (right) in terms of variables Si(t) (solid) for each sub-population, and I(t) (dashed).
https://doi.org/10.1371/journal.pcbi.1006069.g007
Table 4. Case study 2—Studying the predictive power of m.
Pair Ethnicity (E) Strain (V) m β (×10−4) σ(SPV) (×10−4) CV(SPV) Sk(SPV) FI1 R0
3 Uganda Kampala pop 2 A/Canada-NFL/RV3019/ 2009 11 0.4 0.63 1.58 1.25 0.10 1.21
4 USA Alaska Yupik A/California/ 07/2009 11 0.87 0.55 0.63 −0.71 0.66 2.60
β and σ(SPV) have units person−1day−1. Histograms of each susceptibility profile SPV(E, V), together with the dynamics of each epidemic, are shown in Fig 7.
https://doi.org/10.1371/journal.pcbi.1006069.t004
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Epidemic size largely correlates with select pairs of parameters
Earlier, we examined the correlation between FI1 and the SPV characteristics θ 2 {m, β, CV
(SPV), σ(SPV), Sk(SPV)} independently. This raises the question of whether accounting for
pairs of such parameters might provide a more accurate prediction of FI1. We study here how
pairs of parameters are related to epidemic size in all (E, V) pairs with 1< R0 < 7 and m> 1.
We find that pairs involving the average susceptibility β, as well as the heterogeneity parame-
ters Sk(SPV), CV(SPV) and σ(SPV) are better predictors of the final epidemic size than these
quantities individually. Plots involving these parameters are shown in Fig 9, while multiple
correlation coefficients are shown in Table 5. All other parameter pairs are plotted in support-
ing information; see S2 Fig. In particular, note that:
• Epidemic pairs containing a susceptibility profile vector leading to large values of CV(SPV),
small values of β, and positive Sk(SPV) experience smaller final epidemic sizes.
• Epidemic pairs with positive Sk(SPV) are also the ones with small average susceptibility, and
they lead to small final epidemic sizes.
From Fig 9, we see that for a given β, FI1 decreases with increasing σ(SPV). It also decreases
as Sk(SPV) is made more positive, or as CV(SPV) is increased. This shows that for intermediate
Fig 8. R0 as a function of SPV characteristics. The dependence of the basic reproduction number R0 on several characteristics of the
susceptibility profile vector of each (E, V) pair considering H1N1 strains isolated in 2009: (a) skewness of the SPV; (b) standard deviation of the
SPV; (c) coefficient of variation of the SPV; (d) number of susceptibility sub-populations, m. Only epidemic pairs (E, V) with 1< R0 < 7 and
m> 1 are plotted.
https://doi.org/10.1371/journal.pcbi.1006069.g008
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values of β such as the ones shown in Fig 9, a higher spread in βi values helps to protect the
population against the epidemic spread. In other words, a population with higher genetic het-
erogeneity in susceptibility to a virus, leading to susceptibility sub-populations with a large
spread in susceptibilities, can be expected to have a smaller epidemic than a population where
Fig 9. FI1 as a function of pairs of SPV characteristics. (a) (Sk(SPV), σ(SPV)); (b) (CV(SPV), σ(SPV)); (c) (CV(SPV), β); (d) (Sk(SPV), β); (e) (σ
(SPV), β); (f) (CV(SPV), Sk(SPV)). FI1 is shown as a colourbar.
https://doi.org/10.1371/journal.pcbi.1006069.g009
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most of the people have similar susceptibility, despite both populations being non-homoge-
neous in susceptibility.
We also observe that for a given value of β, an (E, V) pair with Sk(SPV)> 0 or only slightly
negative corresponds to a smaller FI1 than one for which Sk(SPV) is a large negative value.
We interpret this in the following way: populations containing a small sub-set of individuals
with heightened susceptibility, but in which most of the individuals are less susceptible, are
better protected against the disease than populations where the susceptibility is more uni-
formly distributed, even if the mean susceptibility is the same.
We provide in Table 5 multiple correlation coefficients
rððy1; y2Þ; tÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
rðy1; tÞ
2
þ rðy2; tÞ
2
  2rðy1; tÞrðy2; tÞrðy1; y2Þ
q
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1   rðy1; y2Þ
2
q 2 ð0; 1Þ
between our summary statistics τ 2 {FI1, R0} and SPV characteristics pairs (θ1, θ2) 2 {m, β, CV
(SPV), σ(SPV), Sk(SPV)}2.
Predictions broadly track trends in pH1N1 (2009) burden
The 2009 pandemic of H1N1 was closely tracked by many organisations in the world, includ-
ing the World Health Organization (WHO). For example, [62, Fig 3] indicates that certain
areas of the world experienced a larger number of cases than others. In particular, we see that
China and Japan experienced worse epidemics than Russia, which tends to have relatively
smaller epidemics.
To compare the predictions of our model with these observations, we select viral strains iso-
lated in these regions during the 2009 pandemic, and ethnicities corresponding to these coun-
tries. We would like to mention here that our model works with individual ethnicities, while
the data available is for countries, which are comprised of multiple ethnicities. We find that
different ethnicities from the same country experience widely differing epidemic sizes for the
same viral strain; see S1 File. For this comparison, we select ethnicities available in our data set
from each of these countries, for which the predictions most closely resemble the observations
in [62, Fig 3]; see Fig 10. As can be seen in Fig 10, our method predicts that most Chinese eth-
nicities will experience severe epidemics regardless of the viral strain. On the other hand, Rus-
sia and Japan are predicted to experience smaller epidemics for most viral strains. However,
Table 5. Correlation coefficients r((θ1, θ2), τ) between summary statistics of the epidemic and SPV characteristics
pairs.
SPV Characteristic Pair (θ1, θ2) FI1 R0
(β, m) 0.81 1.0
(β, CV(SPV)) 0.88 1.0
(β, σ(SPV)) 0.87 1.0
(β, Sk(SPV)) 0.80 1.0
(m, CV(SPV)) 0.62 0.24
(m, σ(SPV)) 0.55 0.72
(m, Sk(SPV)) 0.53 0.24
(CV(SPV), σ(SPV)) 0.78 0.86
(CV(SPV), Sk(SPV)) 0.62 0.20
(σ(SPV), Sk(SPV)) 0.48 0.75
https://doi.org/10.1371/journal.pcbi.1006069.t005
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we note that for most of the Japanese strains, the Japanese ethnicity will suffer larger epidemic
sizes than the Russian one, thus qualitatively agreeing with what can be observed in [62, Fig 3].
An interesting case is the strain A/Japan/921/2009 (H1N1), which was one of the strains cir-
culating in Japan during the 2009 pandemic. This strain is predicted to cause severe epidemics
in most ethnicities, and this holds true across all the 61 ethnicities considered in the data set.
The ethnicity Russia Tuva Pop 2 is predicted to experience moderate epidemics for viral
strains isolated in Russia, but a slightly worse epidemic for the strain A/Hyogo/2/2009
(H1N1), isolated in Japan. Thus, our methods bear out the idea that the severity of an influenza
epidemic in a given country should not be dictated entirely by the genetic makeup of the hosts,
but should also depend on the particular strain of the pathogen circulating in this country.
Our predictions suggest that the ability of HLA class-I alleles in the ethnicity Russia Tuva pop
2 to present epitopes from the influenza A (H1N1) virus changes significantly across different
viral strains.
The results described above show that even with a model that only incorporates susceptibil-
ity heterogeneities in terms of epitope presentation through HLA class-I alleles, we can quali-
tatively explain some essential trends observed across the world during the 2009 H1N1
pandemic. This serves as a qualitative validation of our methodology. Moreover, our results
suggest that while some trends in influenza spread worldwide can be explained by the average
susceptibility of each ethnicity to each strain, others might have an explanation related to the
particular genetic diversity within each ethnicity for a given strain. For example, when analys-
ing pairs 5 and 6 in Table 6, we can see that the same value of β can lead to different epidemic
sizes for the same strain when considering the China Yunnan Province Lisu and the Japan
pop 5 ethnicities. This is likely related to the fact that Sk(SPV) is significantly more negative
for the Chinese ethnicity, and the coefficient of variation is smaller, leading to a larger epi-
demic size. A similar behaviour can be seen when considering pairs 7-9 in Table 6. Larger
reproduction numbers can still arise from smaller epidemic sizes if Sk(SPV) is closer to 0 (or
positive), and for more heterogeneous populations (larger values of CV(SPV)), which might
explain smaller epidemic sizes in, for example, the Kenya Luo ethnicity compared to the Chi-
nese ones [62, Fig 3].
Fig 10. Qualitative trends captured by our model. Epidemic sizes predicted by our model for different ethnicities and strains corresponding to
China, Russia, and Japan, during the 2009 influenza A/H1N1 pandemic. Qualitatively, the predictions broadly track trends observed worldwide.
https://doi.org/10.1371/journal.pcbi.1006069.g010
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Similar trends are observed in H1N1 strains isolated in years other than
2009
We carry out parameter estimation and simulations as described in previous sections, for 85
strains of H1N1 influenza isolated in years other than 2009. This includes 15 strains isolated
before 2000, 21 strains isolated between 2000 and 2008 (inclusive), and 49 strains isolated after
2009. We find that the trends identified in Fig 9 apply even for these strains; see supporting
information S3 Fig.
Response of some indigenous ethnicities to H1N1
Several studies have reported that during the 2009 pandemic, indigenous ethnicities experi-
enced more severe epidemics than their non-indigenous counterparts [63–65]. The indigenous
ethnicities in our data set are USA Alaska Yupik, Australia Yuendumu Aborigine, and Austra-
lia Cape York Peninsula Aborigine. We find that the ethnicity USA Alaska Yupik is always pre-
dicted to have a worse epidemic than non-indigenous ethnicities from the USA, irrespective of
the strain being considered. Since our data set does not include any non-indigenous ethnicities
from Australia, we are unable to verify whether or not a similar statement holds true for the
Australian aboriginal ethnicities.
In general, we find the ethnicity Australia Cape York Aborigine, with average FI1 = 0.14
when considering all 166 viral strains, is predicted to experience a marginally worse epidemic
than Australia Yuendumu Aborigine whose average FI1 = 0.08. Interestingly, this trend is
reversed when we focus on the strains A/Auckland/1/2009 and A/Auckland/597/2000 isolated
in Australia. For these strains, Australia Cape York Aborigine has R0 < 1 for both these strains,
but Australia Yuendumu Aborigine has R0 = 1.49 for the strain A/Auckland/1/2009; see
Table 7.
Based on the observations during the 2009 pandemic, it has been suggested that aboriginal
communities should be prioritised during vaccination [63, 64]. However the predictions in
Table 6. Select case studies to study the observed behaviour in Fig 10.
Pair Ethnicity (E) Strain (V) m β(×10−4) σ(SPV) (×10−4) CV(SPV) Sk(SPV) FI1 R0
5 China Yunnan Province Lisu A/Kyoto/ 08K056/2009 2 0.42 0.03 0.07 −14.64 0.37 1.25
6 Japan pop 5 A/Kyoto/ 08K056/2009 4 0.42 0.24 0.57 −0.77 0.30 1.27
7 China Guizhou Province Shui A/Fukuoka-C/3/2009 2 0.84 0.13 0.15 −5.87 0.88 2.51
8 China Yunnan Province Lisu A/Fukuoka-C/3/2009 5 1.15 0.47 0.41 −1.77 0.84 3.45
9 Kenya Luo A/Japan/ 921/2009 4 1.23 1.01 0.82 −0.02 0.67 3.68
Epidemic pairs with similar R0 have different epidemic sizes, governed by their genetic heterogeneity. β and σ(SPV) have units person−1day−1.
https://doi.org/10.1371/journal.pcbi.1006069.t006
Table 7. Case study 3—Studying Australian aboriginal ethnicities.
Pair Ethnicity (E) Strain (V) m β (×10−4) σ(SPV) (×10−4) CV(SPV) Sk(SPV) FI1 R0
10 Australia Yuendumu Aborigine A/Auckland /1/2009 1 0.5 0 0 NA 0.57 1.49
11 Australia Yuendumu Aborigine A/Auckland /597/2000 1 0.28 0 0 NA 0.0006 0.82
12 Australia Cape York Peninsula Aborigine A/Auckland /1/2009 3 0.33 0.1 0.3 −1.8 0.006 0.98
13 Australia Cape York Peninsula Aborigine A/Auckland /597/2000 3 0.19 0.05 0.26 −1.93 0.0002 0.58
β and σ(SPV) have units person−1day−1. Since Sk(SPV) can only be calculated when there are m> 1 sub-populations, Sk(SPV) = NA (Not Applicable) for epidemic pairs
10 and 11.
https://doi.org/10.1371/journal.pcbi.1006069.t007
Impact of genetic heterogeneity on epidemiology of H1N1 influenza
PLOS Computational Biology | https://doi.org/10.1371/journal.pcbi.1006069 March 21, 2018 23 / 32
Table 7 suggest that at least from the perspective of HLA alleles and downstream CTL
response, each influenza strain and each aboriginal community needs to be assessed indepen-
dently. Using our model, it is possible to predict whether or not a new strain will cause a worse
epidemic than a strain in the data set, within the constraints of the assumptions made. Predic-
tions such as these could help optimise the deployment of resources when combating a new
strain of influenza.
High risk alleles for one strain do not always correlate with severe
epidemics in general
The frequency of the HLA class-I allele HLA-A24 has been found to correlate with mortality
rate due to the pandemic H1N1 (2009) influenza virus [36]. We rank ethnicities in our data set
in descending order of their average FI1 across all 166 strains of influenza, and find that the
ethnicity USA Alaska Yupik has the highest prevalence of allele HLA-A24:02, and also has the
worst average epidemic size; see Table 8. The ethnicity with the next highest frequency of allele
HLA-A24:02, Japan Central, has very low average epidemic size, and ranks 52nd among 61
ethnicities. The ethnicity Japan pop 3 has comparable frequency of the allele HLA-A24:02 as
Japan Central, but is ranked 28th based on its average epidemic size. These results show that an
allele whose frequent occurrence correlates with a high risk for one influenza strain, does not
always correlate with a severe epidemic when considering influenza strains in general. Rather,
we need to estimate the full profile of the SPV, or at least the summary characteristics with
strong correlation as described in previous sections.
Synthetic data supports the observed behaviour
Does the behaviour discussed in the preceding sections rely on correlations between SPV char-
acteristics that are specific to the epidemic pairs we analyse? These correlations arise directly
from genetic heterogeneities at the HLA genotype level corresponding to the 61 ethnicities and
166 viral strains considered here. However, we could frame our questions more generally. For
example, we could ask if a positive skewness of the SPV would always be a protective character-
istic for the population, given a fixed average β?
To address these and similar questions, we construct a synthetic data set of 104 epidemic
pairs created within the following parameter ranges:
m  Uintðf2; . . . ; 15gÞ;
ei ¼ 2 u 10
pi ; 1  i  m;
u  Uð0; 1Þ; pi  Uðlog10ðeminÞ; log10ðemaxÞÞ; 1  i  m;
Ni  Uintðf1; . . . ;NgÞ; 1  i  m s:t:
Xm
i¼1
Ni ¼ N;
where emin and emax are the minimum and maximum values of ei in the real data set analysed
Table 8. Top 3 ethnicities with high risk allele HLA-A24:02.
Ethnicity (E) Allele frequency rank Frequency Average FI1 Average FI1 rank
USA Alaska Yupik 1 58% 0.68 3
Japan Central 2 38% 0.009 52
Japan pop 3 3 36% 0.02 28
Higher average FI1 rank implies more severe predicted epidemic. Ranks are out of the 61 ethnicities considered in this data set.
https://doi.org/10.1371/journal.pcbi.1006069.t008
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in previous sections. These distributions have been chosen so that we obtain 104 epidemic
pairs with values in the interval 1< R0 < 7, m> 1, with Ni and βi distributed within ranges
that are comparable to those of the original data set.
For this synthetic data set, we plot in Fig 11 the predicted final epidemic size as a function
of the different SPV characteristics. In Tables 9 and 10, correlation coefficients for single and
paired SPV characteristics, and summary statistics FI1 and R0, are provided for the epidemic
Fig 11. FI1 as a function of SPV characteristics—Synthetic data set. Dependence of epidemic size on several characteristics of the SPV is
analysed for the synthetic data set described in the text. (a) β; (b) Sk(SPV); (c) σ(SPV); (d) CV(SPV); (e) m.
https://doi.org/10.1371/journal.pcbi.1006069.g011
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pairs in this synthetic data set. A direct inspection of results in Fig 11 and Tables 9 and 10 lead
to the following conclusions:
• Large values of β lead to larger epidemic sizes. However, β alone can not explain FI1, and
other characteristics of the SPV need to be taken into account, as for the original data set; see
Fig 11(a).
• Positive skewness leads to smaller epidemic sizes than negative skewness scenarios, as
observed for the original data set; see Fig 11(b).
• The larger the heterogeneity (in terms of σ(SPV) or CV(SPV)), the more protected the popu-
lation is against epidemic spread. This is not a consequence of the value of m. Rather, it is the
particular combination of βi and Ni values which has an impact on the epidemic dynamics;
see Fig 11(c)–11(e).
Discussion
Theoretical studies on epidemiological spread of disease in the presence of susceptibility het-
erogeneities have shown that final epidemic size is typically lower when susceptibility sub-pop-
ulations are factored in, as compared to the case of homogeneous susceptibility [21, 44, 61].
We find that this result holds true when the sub-population sizes and disease transmission
rates are informed by real-world data about immunological factors. The novelty in our
approach is to propose how the susceptibility profile vector can be estimated from genetic
sequence data, so that we can then deal with particular SPVs that might exist in reality for dif-
ferent ethnicities and viral strains. We also show that some summary statistics of the SPV
(such as the skewness or the coefficient of variation) can help to better understand the pre-
dicted final size of the epidemic.
Table 9. Correlation coefficients r(θ, τ) between summary statistics of the epidemic and SPV characteristics for
the synthetic data set.
SPV Characteristic θ FI1 p-value R0 p-value
m −0.2 < 10−3 0.02 0.03
β 0.62 < 10−3 1.00 < 10−3
CV(SPV) −0.58 < 10−3 −0.06 < 10−3
σ(SPV) −0.06 < 10−3 0.61 < 10−3
Sk(SPV) −0.40 < 10−3 −0.12 < 10−3
https://doi.org/10.1371/journal.pcbi.1006069.t009
Table 10. Correlation coefficients r((θ1, θ2), τ) between summary statistics of the epidemic and SPV characteristics
pairs, for the synthetic data set.
SPV Characteristic Pair (θ1, θ2) FI1 R0
(β, m) 0.66 1.0
(β, σ(SPV)) 0.83 1.0
(β, Sk(SPV)) 0.70 1.0
(β, CV(SPV)) 0.83 1.0
(m, σ(SPV)) 0.21 0.62
(m, Sk(SPV)) 0.34 0.14
(m, CV(SPV)) 0.58 0.07
(CV(SPV), σ(SPV)) 0.73 0.88
(CV(SPV), Sk(SPV)) 0.58 0.13
(σ(SPV), Sk(SPV)) 0.42 0.75
https://doi.org/10.1371/journal.pcbi.1006069.t010
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A limitation of our model is that factors such as age, prior infection history and vaccination
are not included. While there have been studies which collect and analyse such data for small
cohorts [47, 48, 65], gathering such information on the global scale required for this analysis
requires the formation of consortia such as those existing for diseases such as cancer [37].
Also, we make the strong simplifying assumption that all aspects of the innate and adaptive
immune system not affected by HLA class-I presentation can be pooled into a single propor-
tionality constant, and are considered uniform among individuals within an ethnicity, and
across ethnicities. While this helped focus the analysis on the role of HLA alleles in disease
spread, incorporating other aspects of the immune system into epidemiological models is an
important problem that must be addressed. Due to these limitations, predictions made by our
model can only be used to draw comparisons between different epidemic pairs, particularly
epidemic pairs consisting of the same ethnicity and different viral strains, and not for making
absolute quantitative predictions.
A number of extensions of the line of work presented in this manuscript are possible. Pre-
sentation of epitopes by HLA class-I alleles is preceded by a number of steps including interna-
lisation of the virus, proteasomal cleavage of viral proteins into shorter peptides, and transport
of peptides through the TAP transport system [31]. The epitope prediction tools used in this
work do not explicitly consider all these pre-processing steps in any single tool. Also, the pre-
diction algorithms have lower accuracy for rare alleles. The model can be improved by plug-
ging in different epitope prediction methods which overcome these limitations. Also, it would
be useful to establish a more accurate, quantitative connection between si and ei than the sim-
ple inverse relation we have assumed. Two other possible mathematical forms, si/ 1/ln(ei + 1)
and si/ 1/(ei + 1)2, are explored in the supporting information; see S4 Fig.
Spatial heterogeneities are known to allow for disease persistence, since asynchrony in the
epidemic spread among different sub-populations located in different geographical locations
can allow for global persistence, even if the epidemic locally dies out [19]. Since HLA alleles
are inherited, it can be expected that families and households will have similar HLA genotypes,
potentially introducing spatial inhomogeneity in the distribution of HLA alleles in a popula-
tion. If such spatial information regarding HLA genotypes were gathered, it would be interest-
ing to study how this affects epidemic dynamics and persistence. An agent based model
incorporating variations in agent susceptibility along the lines indicated here, along with spa-
tial information regarding each susceptible agent, would provide an idea of how such factors
might modify the general conclusions described in this paper. A network model incorporating
the social structure of individual contacts would indicate if the combination of varied suscepti-
bility with a specified contact network structure between individuals might accelerate epi-
demic progress or retard it.
Conclusions
The incorporation of within-host immunological information into population-level epidemic
models is a major challenge for epidemiological modeling [30]. In this paper, we address this
question in a specific case, by modeling the impact of genetic diversity in terms of the HLA
class-I genotype on the predicted epidemic dynamics of H1N1 influenza. To do this, we made
use of HLA allele frequencies measured across different ethnicities, focusing on the number of
high affinity epitopes presented by individuals within 61 ethnicities and for 81 H1N1 influenza
A viral strains isolated in 2009 as well as 85 H1N1 influenza A viral strains isolated in other
years. Our main hypothesis was that the susceptibility of individuals in a given ethnicity, for a
given viral strain, is inversely proportional to the number of high affinity epitopes that these
individuals can present. We then used a multi-compartment SIR model to study the spread
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dynamics of influenza for each (ethnicity, viral strain) epidemic pair, where the final epidemic
size FI1 and the basic reproduction number R0 are used as the summary statistics for the pur-
pose of comparison.
While the average susceptibility β is a central parameter, the susceptibility profile corre-
sponding to each epidemic pair also plays an important role governing epidemic spread. In
particular, when analysing epidemics with intermediate values of β (i.e., intermediate values of
R0), more heterogeneous susceptibility profiles, as well as profiles showing positive skewness
Sk(SPV), are more protective for the population as a whole against H1N1 influenza. Our
model only considers heterogeneity from the perspective of the ability of a person’s HLA geno-
type to present epitopes from a given virus. However, even if at a qualitative level, our results
support the idea that having a wide variety of HLA alleles represented among its individuals,
resulting in a wide range of susceptibilities, benefits a population as a whole in terms of
restricting the spread of an infectious disease.
Although our model does not incorporate other factors such as social and economic char-
acteristics of each particular population or potential different infectivities for each viral
strain, our results qualitatively capture several central trends of influenza spread worldwide.
Thus, we can conclude that susceptibility of individuals in terms of the HLA genotype is
an important factor that could explain the spread potential of different influenza viral
strains among different ethnicities and populations. While some of these trends can just be
explained due to larger or smaller values of R0 (i.e., the average susceptibility β), the reason
for small epidemic sizes occurring for some particular ethnicities and viral strains might be
related to the existence of high genetic diversity resulting in a wide range of susceptibilities
in these populations, for these viral strains, with a positively skewed susceptibility profile
vector.
Supporting information
S1 Fig. Variations in SPV characteristics, non-2009 strains. Histograms for the values of the
different susceptibility profile vector characteristics for the 5, 185 epidemic pairs involving
H1N1 strains isolated in years other than 2009: (a) σ(SPV); (b) Sk(SPV); (c) CV(SPV); (d) m;
and (e) β.
(TIF)
S2 Fig. FI1 as a function of other pairs of SPV characteristics, 2009 strains. (a) (CV(SPV),
m); (b) (Sk(SPV), m); (c) (σ(SPV), m) and (d) (β, m).
(TIF)
S3 Fig. FI1 trends hold for H1N1 strains isolated before and after 2009. FI1 as a function
of pairs of SPV characteristics. (a) (Sk(SPV), σ(SPV)); (b) (CV(SPV), σ(SPV)); (c) (CV(SPV), β);
(d) (Sk(SPV), β); (e) (σ(SPV), β); (f) (CV(SPV), Sk(SPV)). FI1 is shown as a colourbar.
(TIF)
S4 Fig. Other mathematical forms for si / 1ei. The results presented in the paper use the form
si / 1ei (column 1). Two other mathematical forms, si /
1
lnðeiþ1Þ
(column 2) and si / 1ðeiþ1Þ2 (col-
umn 3) are explored here, for all 61 ethnicities and 166 viral strains. Only the pairs of SPV
characteristics found to have high correlation with FI1 are shown. (a, b, c) (σ(SPV), β); (d, e, f)
(CV(SPV), β); (g, h, i) (Sk(SPV), β). FI1 is shown as a colourbar. Trends in epidemic size hold
across all considered mathematical forms.
(TIF)
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S1 File. All calculated parameters. Parameters m, β, βi, xi, σ(SPV), CV(SPV), Sk(SPV), FI1
and R0 for all epidemic pairs in the data set.
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